VBI Vaccines Inc (VBV) Director Purchases C$17,882.92 in Stock

VBI Vaccines Inc (TSE:VBV) Director Jeffrey Royston Baxter acquired 4,609 shares of the stock in a transaction dated Tuesday, December 12th. The stock was acquired at an average price of C$3.88 per share, for a total transaction of C$17,882.92.

Jeffrey Royston Baxter also recently made the following trade(s):

  • On Tuesday, November 28th, Jeffrey Royston Baxter acquired 15,000 shares of VBI Vaccines stock. The stock was acquired at an average price of C$4.75 per share, for a total transaction of C$71,250.00.

Shares of VBI Vaccines Inc (TSE VBV) traded down C$0.08 during trading on Friday, hitting C$5.72. The stock had a trading volume of 5,434 shares, compared to its average volume of 5,462. VBI Vaccines Inc has a fifty-two week low of C$3.85 and a fifty-two week high of C$8.94. The stock has a market capitalization of $288.82, a P/E ratio of -6.29 and a beta of 1.84.

COPYRIGHT VIOLATION NOTICE: This report was originally reported by Community Financial News and is owned by of Community Financial News. If you are viewing this report on another domain, it was copied illegally and republished in violation of US & international trademark and copyright laws. The legal version of this report can be accessed at https://www.com-unik.info/2017/12/23/vbi-vaccines-inc-vbv-director-purchases-c17882-92-in-stock.html.

VBI Vaccines Company Profile

VBI Vaccines Inc, a commercial stage biopharmaceutical company, develops vaccines to address unmet needs in infectious disease and immuno-oncology in Israel and internationally. It is developing eVLP, a vaccine platform for the design of enveloped virus-like particle vaccines; and Lipid Particle Vaccine technology, a vaccine formulation technology that enables the thermostabilization of vaccines through a proprietary formulation and freeze-drying process.

Receive News & Ratings for VBI Vaccines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VBI Vaccines and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit